Trials / Recruiting
RecruitingNCT06922175
REACH: RWE Retrospective Study to Evaluate Cenobamate Impact on Health Care Resource Utilization
Retrospective Evaluation of Cenobamate's Health Care Resources Utilization (HCRU) in the Management of Uncontrolled Focal Onset Seizures- A Retrospective, Chart Review Study
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- Aziende Chimiche Riunite Angelini Francesco S.p.A · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The Study is an observational, retrospective study which aim is to assess cenobamate's healthcare resources utilization (HCRU) in the management of uncontrolled focal onset seizures. The amin objective is to compare the resource utilization before and after the use of cenobamate. Data from medical charts will be used and inserted into the eCRF from which the analyses will be conducted. Data from 200 patients from 10 sites in 5 countries are included.
Conditions
Timeline
- Start date
- 2024-12-19
- Primary completion
- 2025-12-30
- Completion
- 2025-12-30
- First posted
- 2025-04-10
- Last updated
- 2025-10-02
Locations
10 sites across 5 countries: Germany, Netherlands, Spain, Switzerland, United Kingdom
Source: ClinicalTrials.gov record NCT06922175. Inclusion in this directory is not an endorsement.